Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Ozone therapy might improve cancer treatment and reduce its side effects.

FDG PET/CT scans can change cancer treatment plans for dogs.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Treatments for melanin disorders exist, but more effective options needed.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Scientists made a mouse that shows how a specific protein in the skin changes and affects hair growth and shape.

Tooth papilla cells can help regenerate hair follicles and grow hair.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Selenium can be toxic to animals, causing serious health issues, especially in horses.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Tadalafil and Finasteride may help treat aggressive melanoma.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.